Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Cellular and Infection Microbiology|June 27, 2022
Adapt or Die: Targeting Unique Transmission-Stage Biology for Malaria EliminationMariëtte E van der Watt, Janette Reader, Lyn-Marié Birkholtz
Journal of Ethnopharmacology|July 19, 2022
In vitro dual activity of Aloe marlothii roots and its chemical constituents against Plasmodium falciparum asexual and sexual stage parasitesSephora Mutombo Mianda, Luke Invernizzi, Mariëtte E van der Watt, et al.
International Journal for Parasitology. Drugs and Drug Resistance|June 7, 2020
Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural productsPhanankosi Moyo, William Shamburger, Mariëtte E van der Watt, et al.
Chembiochem : a European Journal of Chemical Biology|September 15, 2022
New Transmission-Selective Antimalarial Agents through Hit-to-Lead Optimization of 2-([1,1'-Biphenyl]-4-carboxamido)benzoic Acid DerivativesJanette Reader, Daniel F L Opperman, Mariëtte E van der Watt, et al.
ACS Infectious Diseases|August 14, 2024
The Tuberculosis Drug Candidate SQ109 and Its Analogs Have Multistage Activity against Plasmodium falciparumSavannah J Watson, Mariëtte E van der Watt, Anjo Theron, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2018
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarialsMariëtte E van der Watt, Janette Reader, Alisje Churchyard, et al.
Nature Communications|January 12, 2021
Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response BoxJanette Reader, Mariëtte E van der Watt, Dale Taylor, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2018
UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of MalariaChristel Brunschwig, Nina Lawrence, Dale Taylor, et al.
Pageof 1